Orchid Pharma (LUX:ORCHP) ROCE %: 6.34% (As of Mar. 2026)


LUX:ORCHP Orchid Pharma Ltd LUX:ORCHP
60 GF Score
Price $5.45
GF Value $4.72
! 10 Warning Signs
View Full Analysis

What is Orchid Pharma ROCE %?

Orchid Pharma LUX:ORCHP 60 ROCE % is 6.34% as of Mar. 2026. GuruFocus rates LUX:ORCHP with a GF Score™ of 60/100 and a GF Value™ of $4.72. The stock has 10 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Orchid Pharma's annualized ROCE % for the quarter that ended in Mar. 2026 was 6.34%.

Orchid Pharma  (LUX:ORCHP) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Orchid Pharma ROCE % Related Terms

Orchid Pharma ROCE % Historical Data

* Premium members only.

The historical data trend for Orchid Pharma's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Orchid Pharma ROCE % Chart

Orchid Pharma Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.47 9.76 10.05 8.01 2.19

Orchid Pharma Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.56 4.88 0.11 -2.33 6.34
LUX:ORCHP
60GF Score
Orchid Pharma Ltd LUX:ORCHP
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Orchid Pharma ROCE % Calculation

Orchid Pharma's annualized ROCE % for the fiscal year that ended in Mar. 2026 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Mar. 2026 )  (A: Mar. 2025 )(A: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Mar. 2026 )  (A: Mar. 2025 )(A: Mar. 2026 )
=3.693/( ( (195.086 - 33.006) + (205.877 - 30.056) )/ 2 )
=3.693/( (162.08+175.821)/ 2 )
=3.693/168.9505
=2.19 %

Orchid Pharma's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=11.152/( ( (0 - 0) + (205.877 - 30.056) )/ 1 )
=11.152/( ( 0 + 175.821 )/ 1 )
=11.152/175.821
=6.34 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 6.34% mean?
Orchid Pharma (LUX:ORCHP) has a ROCE % of 6.34% as of Mar. 2026.
Is Orchid Pharma's ROCE % too high?
Orchid Pharma's current ROCE % is 6.34%. The Drug Manufacturers industry median ROCE % is 7.00. Orchid Pharma's value of 6.34% is 9.4% below this industry median. Overall, Orchid Pharma has a GF Score™ of 60/100, reflecting its overall financial health beyond just this single metric.
How does Orchid Pharma's ROCE % compare to ZTS?
Orchid Pharma's ROCE % of 6.34% can be compared against companies in the Drug Manufacturers industry. The industry median ROCE % is 7.00. Orchid Pharma's value of 6.34% is 9.4% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Drug Manufacturers company?
The median ROCE % among Drug Manufacturers companies is 7.00, based on 958 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Orchid Pharma's current ROCE % of 6.34% is 9.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Drug Manufacturers industry, the median ROCE % is 7.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Orchid Pharma's current ROCE % is 6.34%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Orchid Pharma stock overvalued right now?
Orchid Pharma (LUX:ORCHP) has a current ROCE % of 6.34%. The stock's GF Value™ is $4.72, compared to a current price of $5.45 — trading 15.5% above its estimated fair value. The current ROCE % is 6.34% and 9.4% below the Drug Manufacturers industry median of 7.00. Orchid Pharma's overall GF Score™ is 60/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Orchid Pharma (LUX:ORCHP), the current ROCE % is 6.34% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Orchid Pharma (LUX:ORCHP) Overvalued in 2026?

Based on GuruFocus' analysis, Orchid Pharma stock appears to be overvalued. The current stock price of $5.45 is trading 15.5% above its estimated GF Value™ of $4.72.

Key valuation signals for LUX:ORCHP:

  • ROCE %: 6.34%
  • GF Value™: $4.72 vs. price of $5.45 (15.5% above fair value)
  • GF Score™: 60/100 with 10 warning signs
  • Industry Position: 9.4% below the Drug Manufacturers median

No single metric tells the full story. See the LUX:ORCHP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Orchid Pharma Business Description

Address Sector 74A, 15th Floor, Tower-1, DLF Corporate Greens, Narsinghpur, Gurugram, HR, IND, 122004
Orchid Pharma Ltd is involved in the development, manufacturing, and marketing of diverse bulk actives, formulations, and nutraceuticals. The company operates in one business segment, which is Pharmaceuticals, in which the company derives its maximum sales through Active Pharmaceutical Ingredients. It produces various products such as tablets, injectables, and APIs for cardiovascular, anti-diabetic, neuropsychiatry, veterinary, non-antibiotic, and cephalosporins. The products are grouped under formulations and active pharmaceutical ingredients. Geographically, the company generates maximum revenue from the export of its products to international markets like the United States, Canada, Europe, Japan, Australia, and China etc., and the rest from its business in India.
60GF Score

Get the complete analysis for LUX:ORCHP

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$5.45
Price
$4.72
GF Value